Weill Cornell Imaging at NewYork-Presbyterian
416 East 55th Street
New York, NY 10022
New and Existing Patients
Already a patient?
Login or sign-upto Connect Patient Portal to make an appointment
Locations and Appointments
Insurances Accepted
Please contact the doctor's office to verify that your insurance is accepted.
AETNA
Aetna - NYP
Anthem Blue Cross/Blue Shield
Anthem Blue Cross/Blue Shield Healthplus
GHI
Health Insurance Plan of NY (HIP)
Oxford Health Plans
United Healthcare
VNSNY CHOICE
About Preethi Guniganti, M.D.
Expertise
- Abdominal Imaging
- Abdominal Ultrasound
- Body Imaging
- Body MRI
- Cancer Screening
- Carotid Ultrasound
- Colon Cancer Screening
- CT Scan of the Abdomen
- CT Scan of the Body
- Fluoroscopy
- Gastrointestinal Radiology
- Genitourinary Radiology
- Gynecologic Ultrasound
- Hepatobiliary Pancreas Imaging
- Kidney Transplantation
- Liver Transplantation
- Magnetic Resonance Imaging
- MRA of the Kidneys
- MRI Liver
- MRI of the Abdomen
- MRI Pelvis Female
- Pelvic Ultrasound
- PET Scan
- PET-CT
- Positron Emission Tomography
- Testicular Ultrasound
- Transvaginal Ultrasound
- Ultrasound
- Vascular Ultrasound
- Virtual Colonoscopy
Education
- Degrees: Brown University
- Degrees: Washington University School of Medicine
Languages
- English
Titles & Positions
- Assistant Attending Radiologist
- Assistant Professor of Clinical Radiology
Hospital Affiliations
- NewYork-Presbyterian / Weill Cornell Medical Center
- NewYork-Presbyterian Brooklyn Methodist Hospital
- Newyork-Presbyterian Gracie Square Hospital
- NewYork-Presbyterian Lower Manhattan Hospital
- Newyork-Presbyterian Westchester Behavioral Health
Education
- Degrees: Washington University School of Medicine
- Degrees: Brown University
Titles & Positions
- Assistant Attending Radiologist
- Assistant Professor of Clinical Radiology
Languages Spoken
- english
Research
Neoadjuvant Botensilimab/Balstilimab for localized mismatch repair proficient and deficient colon cancer: Results of the NEST phase 2 clinical trial.
August 26, 2026Reply to Letter to the Editor to "Whole-Body MRI, ethical concerns and, equity of access in healthcare: Where we are? Where we are going?".
July 14, 2026Molecular complete response to the RIN protocol (regorafenib, ipilimumab, and nivolumab) in a patient with advanced recurrent metastatic mismatch repair proficient/microsatellite stable (pMMR/MSS) rectal cancer.
March 19, 2026